About Predictive Oncology (NASDAQ: POAI)
The leading edge of a new frontier in drug discovery
Integrating scientific rigor with machine learning • Overcoming challenges of clinical trials • Improving the probability of success • Collaborating with partners in biopharma • Advancing molecules to medicine with confidence and accuracy
Our vision
We bring hope to cancer patients.
Our mission
Our mission at Predictive Oncology is to change the landscape of oncology drug discovery and enable the development of more effective therapies for the treatment of cancer. By harnessing the power of machine learning, scientific rigor and biologics, we can improve the probability of success and advance drug compounds with a higher degree of confidence.
Our why
At the end of the day, we know there is a cancer patient waiting for therapies to be developed, hoping for a new and effective treatment to get into the hands of the clinician that can help improve their quality of life, extend their life or even cure their cancer—we are that hope.
Meet our team
Get to know our Leadership Team and Board of Directors.
Let’s discover and develop together.
We want to hear about your process challenges—and identify ways to solve them together. Complete the form to get in touch with our team of experts.
News & resources
Predictive Oncology CEO Raymond Vennare and Dr. Robert Murphy, an inventor of the engine behind our artificial intelligence (AI) platform and new member of our...
We sat down for a Q&A with investors in a conversation moderated by Shareholder Nathan Reese. Watch our recording of the webcast here.
How Predictive Oncology is changing the landscape of oncology drug discovery and enabling the development of more effective therapies in the treatment of cancer. Listen to highlights...